Microparticle uptake reduces efferocytic capacity of macrophages
Source abstract
Abstract
Macrophages are phagocytic immune cells that play a central role in the clearance of apoptotic cells, pathogens and other foreign bodies including particulates that may be injected for therapeutic purposes. Recent work has demonstrated that macrophages that take up microparticles clear pathogens faster; however, the effect of particle uptake on the clearance of apoptotic cells (efferocytosis) remains unclear. Herein, we use cargo-free, non-stimulatory polymeric particles as a tool to investigate how the uptake of such particles affects the efferocytic function of macrophages. Using primary cells isolated from mice, we demonstrate that the uptake of large ∼3 µm sized microparticles, but not smaller 500 nm sized particles, reduces a macrophage's efferocytic ability in vitro. Notably, this effect is pronounced in non-activated M0-type naïve-like macrophages and absent in activated M1- and M2-like macrophages, highlighting polarization-dependent resilience towards particulate stress. Given that efferocytosis contributes to an immunosuppressive tumor microenvironment (TME), we leveraged the phenomenon of microparticle uptake driven lowering of efferocytosis to target apoptotic cell clearance in the TME. In a BALB/C mouse model bearing 4T1 tumors, we demonstrate that direct injection of large microparticles into the tumors results in slower tumor growth. Collectively, these findings reveal that cargo-free, non-stimulatory polymeric microparticles of a specific size impact the efferocytic function of macrophages, which may be utilized to alter the TME for therapeutic purposes.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Phagocytosis and Immune Regulation · Immune cells in cancer · Immunotherapy and Immune Responses
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Bioengineering, G08 TSH Building, Indian Institute of Science, Bengaluru, India – 560012
Laboratory of Tumour Immune Microenvironment, Regional Centre for Biotechnology, 3rd Milestone, Faridabad-Gurgaon Expressway, Faridabad, India – 121001
Funding
Wellcome Trust DBT India Alliance
References (39)
Show source-provided references
1. Rosales · BioMed Res. Int. · 2017 · 2017 · 110.1155/2017/9042851 ↗
2. Sharma · Trends Pharmacol. Sci. · 2022 · 43 · 30510.1016/j.tips.2022.01.009 ↗
3. Wong · Cell Host Microbe · 2017 · 21 · 71910.1016/j.chom.2017.05.002 ↗
4. Sharma · J. Controlled Release · 2022 · 343 · 13110.1016/j.jconrel.2022.01.030 ↗
5. Salina · Apoptosis · 2024 · 29 · 32110.1007/s10495-023-01899-1 ↗
6. Doran · Nat. Rev. Immunol. · 2020 · 20 · 25410.1038/s41577-019-0240-6 ↗
7. Moon · Exp. Mol. Med. · 2023 · 55 · 164410.1038/s12276-023-01070-5 ↗
8. Mehrotra · Nat. Rev. Drug Discovery · 2022 · 21 · 60110.1038/s41573-022-00470-y ↗
9. Yurdagul · Front. Cardiovasc. Med. · 2018 · 4 · 8610.3389/fcvm.2017.00086 ↗
10. Mohning · Am. J. Physiol.: Lung Cell. Mol. Physiol. · 2018 · 314 · L69
11. Wofford · J. Biomed. Mater. Res. · 2019 · 107 · 121310.1002/jbm.a.36617 ↗
12. Han · Adv. Sci. · 2024 · 11 · 230832510.1002/advs.202308325 ↗
13. Poon · Annu. Rev. Pharmacol. Toxicol. · 2024 · 64 · 33910.1146/annurev-pharmtox-032723-110507 ↗
14. Yang · J. Biomed. Nanotechnol. · 2009 · 5 · 52810.1166/jbn.2009.1061 ↗
15. Quinn · Prog. Biophys. Mol. Biol. · 1989 · 53 · 7110.1016/0079-6107(89)90015-1 ↗
16. Wei · Cell Res. · 1993 · 3 · 2110.1038/cr.1993.3 ↗
17. Peetla · Adv. Drug Delivery Rev. · 2013 · 65 · 168610.1016/j.addr.2013.09.004 ↗
18. Kotlyarov · Membranes · 2022 · 12 · 103610.3390/membranes12111036 ↗
19. Jaumouillé · Front. Immunol. · 2020 · 11 · 109710.3389/fimmu.2020.01097 ↗
20. Miyanishi · Nature · 2007 · 450 · 43510.1038/nature06307 ↗
21. Rothlin · Cell · 2007 · 131 · 112410.1016/j.cell.2007.10.034 ↗
22. Zizzo · J. Immunol. · 2012 · 189 · 350810.4049/jimmunol.1200662 ↗
23. Han · Int. Immunopharmacol. · 2024 · 135 · 11228310.1016/j.intimp.2024.112283 ↗
24. Fernandez-Boyanapalli · Blood · 2010 · 116 · 451210.1182/blood-2010-02-272005 ↗
25. Schif-Zuck · Eur. J. Immunol. · 2011 · 41 · 36610.1002/eji.201040801 ↗
26. Chakraborty · bioRxiv · 202410.1101/2024.12.26.630419 ↗
27. Pacheco · PLoS One · 2013 · 8 · e6098910.1371/journal.pone.0060989 ↗
28. Arienti · Front. Pharmacol. · 2019 · 10 · 89110.3389/fphar.2019.00891 ↗
29. Yang · Cell Death Dis. · 2023 · 14 · 39110.1038/s41419-023-05925-7 ↗
30. Lemke · Cold Spring Harbor Perspect. Biol. · 2013 · 5 · a00907610.1101/cshperspect.a009076 ↗
31. Lee · Mol. Biol. B Cells · 2007 · 18 · 288310.1091/mbc.e06-05-0450 ↗
32. Magenau · Traffic · 2011 · 12 · 173010.1111/j.1600-0854.2011.01272.x ↗
33. Cohen · J. Leukocyte Biol. · 2013 · 94 · 91310.1189/jlb.0413236 ↗
34. Lin · OncoImmunology · 2022 · 11 · 202494110.1080/2162402X.2021.2024941 ↗
35. Zhou · Cell Commun. Signal. · 2020 · 18 · 7110.1186/s12964-020-00542-9 ↗
36. Cheng · Front. Pharmacol. · 2022 · 13 · 97702510.3389/fphar.2022.977025 ↗
37. Qiu · Biomed. Pharmacother. · 2023 · 167 · 11554010.1016/j.biopha.2023.115540 ↗
38. N. N.Giakoumakis , M. A.Rapsomaniki and Z.Lygerou , in Light Microscopy , ed. Y. Markaki and H. Harz , Springer New York , New York, NY , 2017 , vol. 1563 , pp. 243–26710.1007/978-1-4939-6810-7_16 ↗
39. Day · Curr. Protoc. Cytom. · 201210.1002/0471142956.cy0219s62 ↗